Microbes and their hosts form complex ‘super-organisms’ in which symbiotic relationships maintain many key aspects of life. Changes to these microbial communities, through infection, disease or lifestyle, can disrupt vital functions and even promote disease
What is proBiome?
The proBiome plaform performs multi-omics mapping of full microbial communities to determine species composition and examine the causal role of a specific microbiome in selected disease states. It can be used for human, animal, plant and environmental systems, and is currently compatible with 16SrRNA data from Illumina PE & SE, and Pacbio SE.
Implementing state-of-the-art statistics to calculate causal statistics by the comparative weighting of genetic, microbial and external factors proBiome can predict disease development, progression and resistance. By using a combination of biostatistical frameworks and artificial intelligence tools proBiome examines modifiable risk factors to establish the most viable drug targets and biomarkers in microbiome-associated illnesses as well as develop bioremediation approaches.
